US2020197639A1PendingUtilityA1

Smokeless THC and Administration Method Thereof

49
Assignee: LARSON RAYMOND LOUISPriority: Jan 30, 2013Filed: Feb 10, 2020Published: Jun 25, 2020
Est. expiryJan 30, 2033(~6.5 yrs left)· nominal 20-yr term from priority
Inventors:Raymond L. Larson
A61K 31/658A24F 40/10A61M 15/06A24B 15/167A61M 2205/8206A61M 11/042A61K 9/007A61K 9/0078A61K 31/352A61K 31/05
49
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A pharmaceutical composition and administration apparatus includes a portable powered vaporizer with a mouthpiece, smokeless vaporizing element, and a removable chamber. The chamber contains a composition comprising tetrahydrocannabinol (THC), cannabidiol (CBD), FCC grade ethanol, flavoring, pharmaceutical grade nicotine, USP grade aqueous glycerine, USP/EP grade propylene glycol, and USP grade vegetable glycerine. In various formulas the THC may be at concentrations of 1-30%, 30-60% and 60-99%, while CBD concentrations may be 0-15% including other cannabinoids derived from extraction.

Claims

exact text as granted — not AI-modified
1 - 19 . (canceled) 
     
     
         20 . A liquid composition comprising trace-30% wt. tetrahydrocannabinol (THC), trace-15% wt. cannabidiol (CBD), trace-15% wt. cannabinoids other than THC and CBD, and trace-3% wt. nicotine. 
     
     
         21 . The liquid composition of  claim 20  comprising 0.3% wt.-30% wt. THC. 
     
     
         22 . The liquid composition of  claim 21  comprising 3% wt.-30% wt. THC. 
     
     
         23 . The liquid composition of  claim 20  comprising trace-0.3% wt. THC. 
     
     
         24 . The liquid composition of  claim 20  comprising 2% wt.-15% wt. CBD. 
     
     
         25 . The liquid composition of  claim 20  comprising 2% wt.-15% wt. cannabinoids other than THC and CBD. 
     
     
         26 . The liquid composition of  claim 25  comprising 3% wt.-15% wt. cannabinoids other than THC and CBD. 
     
     
         27 . The liquid composition of  claim 20  further comprising trace-25% wt. vegetable glycerine. 
     
     
         28 . The liquid composition of  claim 20  further comprising trace-20% wt. ethanol. 
     
     
         29 . The liquid composition of  claim 20  further comprising trace-4% wt. flavoring. 
     
     
         30 . The liquid composition of  claim 20  further comprising trace-70% wt. glycol. 
     
     
         31 . A pre-loaded syringe filled with the liquid composition of  claim 20 . 
     
     
         32 . A liquid composition comprising 0-30% wt. tetrahydrocannabinol (THC), trace-15% wt. cannabidiol (CBD), trace-15% wt. cannabinoids other than THC and CBD, trace-4% wt. flavoring, and trace-25% wt. vegetable glycerine. 
     
     
         33 . The liquid composition of  claim 32  comprising less than a trace of THC. 
     
     
         34 . The liquid composition of  claim 32  comprising trace-20% wt. ethanol. 
     
     
         35 . The liquid composition of  claim 32  further comprising trace-70% wt. glycol. 
     
     
         36 . A pre-loaded syringe filled with the liquid composition of  claim 32 . 
     
     
         37 . A liquid composition comprising 60% wt.-95% wt. tetrahydrocannabinol (THC), 5% wt.-15% wt. cannabidiol (CBD), trace-10% wt. cannabinoids other than THC and CBD, trace-4% wt. flavoring, and trace-25% wt. vegetable glycerine. 
     
     
         38 . The liquid composition of  claim 37  further comprising trace-70% wt. glycol. 
     
     
         39 . A pre-loaded syringe filled with the liquid composition of  claim 37 .

Join the waitlist — get patent alerts

Track US2020197639A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.